Asparaginase activity levels and monitoring in patients with acute lymphoblastic leukemia
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Asparaginase activity levels and monitoring in patients with acute lymphoblastic leukemia
Authors
Keywords
-
Journal
LEUKEMIA & LYMPHOMA
Volume 59, Issue 8, Pages 1797-1806
Publisher
Informa UK Limited
Online
2017-10-19
DOI
10.1080/10428194.2017.1386305
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivation
- (2016) I. M. van der Sluis et al. HAEMATOLOGICA
- Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivation
- (2016) I. M. van der Sluis et al. HAEMATOLOGICA
- Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration
- (2015) Ching-Hon Pui et al. JOURNAL OF CLINICAL ONCOLOGY
- Asparaginase pharmacokinetics and implications of therapeutic drug monitoring
- (2015) Barbara Asselin et al. LEUKEMIA & LYMPHOMA
- Acute Lymphoblastic Leukemia in Children
- (2015) Stephen P. Hunger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacokinetic and clinical considerations for monitoring asparaginase activity levels during pegaspargase therapy
- (2015) Lydia Benitez et al. PEDIATRIC BLOOD & CANCER
- Activity and Toxicity of IntravenousErwiniaAsparaginase Following Allergy toE.coli-Derived Asparaginase in Children and Adolescents With Acute Lymphoblastic Leukemia
- (2015) Lynda M. Vrooman et al. PEDIATRIC BLOOD & CANCER
- Best Practices in Adolescent and Young Adult Patients with Acute Lymphoblastic Leukemia: A Focus on Asparaginase
- (2015) Nicolas Boissel et al. Journal of Adolescent and Young Adult Oncology
- A prospective study on drug monitoring of PEGasparaginase and Erwinia asparaginase and asparaginase antibodies in pediatric acute lymphoblastic leukemia
- (2014) Wing H. Tong et al. BLOOD
- The glutaminase activity of L-asparaginase is not required for anticancer activity against ASNS-negative cells
- (2014) W. K. Chan et al. BLOOD
- Pharmacokinetic and Pharmacodynamic Properties of Calaspargase PegolEscherichia coliL-Asparaginase in the Treatment of Patients With Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Study AALL07P4
- (2014) Anne L. Angiolillo et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical application of asparaginase activity levels following treatment with pegaspargase
- (2014) Archie Bleyer et al. PEDIATRIC BLOOD & CANCER
- Hyperammonemia secondary to asparaginase: A case series
- (2014) Vicki Nussbaum et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Erwinia asparaginase achieves therapeutic activity after pegaspargase allergy: a report from the Children's Oncology Group
- (2013) W. L. Salzer et al. BLOOD
- Postinduction Dexamethasone and Individualized Dosing ofEscherichia ColiL-Asparaginase Each Improve Outcome of Children and Adolescents With Newly Diagnosed Acute Lymphoblastic Leukemia: Results From a Randomized Study—Dana-Farber Cancer Institute ALL Consortium Protocol 00-01
- (2013) Lynda M. Vrooman et al. JOURNAL OF CLINICAL ONCOLOGY
- Dexamethasone exposure and asparaginase antibodies affect relapse risk in acute lymphoblastic leukemia
- (2011) J. D. Kawedia et al. BLOOD
- L-asparaginase treatment in acute lymphoblastic leukemia
- (2010) Rob Pieters et al. CANCER
- Transient Hyperammonemia Due to L -Asparaginase Therapy in Children with Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma
- (2010) C. Jörck et al. PEDIATRIC HEMATOLOGY AND ONCOLOGY
- The cross-reactivity of anti-asparaginase antibodies against different l-asparaginase preparations
- (2009) Beata Zalewska-Szewczyk et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Is asparaginase a critical component in the treatment of acute lymphoblastic leukemia?
- (2008) Dan Douer BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Pharmacokinetics, pharmacodynamics, efficacy, and safety of a new recombinant asparaginase preparation in children with previously untreated acute lymphoblastic leukemia: a randomized phase 2 clinical trial
- (2008) R. Pieters et al. BLOOD
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started